Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
orion
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adverum biotechnologies
albert bourla
alirocumab
alzheimer's disease
amicus therapeutics
arvinas
batten disease
bayer
biogen
breast cancer
What
drug
acquisitions
albert
biggest
bio
bourla
ceo
cholesterol
company
crispr
drugs
expensive
faces
financial
foe
future
healthcare
hint
imports
inhibitors
known
lowering
maker
maps
measured
new
patients
pcsk
pfizer
pfizer’s
remember
revenue
roundup
supposed
today
tough
wave
world’s
Language
unknown
unset
Current search:
orion
×
biotech
×
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More